S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CNTB Connect Biopharma Holdings Inc

0.98

-0.0182 (-1.82%)

29 Jan 2025 - Closed

Delayed by 15 minutes

Annual and Transition Report (foreign Private Issuer) (20-f)

This article is 7Mb in size. Click here to view

Connect Biopharma (NASDAQ:CNTB)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Connect Biopharma Charts.

Connect Biopharma (NASDAQ:CNTB)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Connect Biopharma Charts.

Connect Biopharma Holdings Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Attovia Therapeutics Appoints Chief Financial Officer
Tuesday 15 October 2024 (3 months ago) • GlobeNewswire Inc.

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024
Tuesday 10 September 2024 (5 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 7 September 2024 (5 months ago) • Edgar (US Regulatory)

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
Friday 6 September 2024 (5 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 3 August 2024 (6 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 13 June 2024 (8 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Wednesday 28 February 2024 (11 months ago) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Wednesday 14 February 2024 (12 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (12 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (12 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 13 February 2024 (12 months ago) • Edgar (US Regulatory)

More Connect Biopharma Holdings Ltd News Articles

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions